Morgan Stanley and Capital Research Global Investors lifted their positions in Eli Lilly, while Cantor Fitzgerald provided new research reports on the stock.

The entities involved

• Eli Lilly and Company →

  American pharmaceutical company

  • ExxonMobil, Berkshire Hathaway, and Eli Lilly are top holdings in the Avantis ETF.Mon 17:18
  • The FDA approved Olumiant for pediatric indications on September 1, 2026.Mon 05:59
• Morgan Stanley →

  U.S. investment bank

  • Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
  • Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24
• Capital Research Global Investors →
  • Capital Research Global Investors acquired and increased its stake in Wells Fargo stock on June 19, 2026.Mon 16:28
  • Investment firms have acquired new and boosted stakes in TSMC shares.Mon 06:05

Related events

• Morgan Stanley increased its stake in Eli Lilly stock, and the company filed required reports with the SEC.Jul 9
• Morgan Stanley and Cantor Fitzgerald raised target prices, while filings detailing stock changes were submitted to the SEC.Aug 17
• Cantor Fitzgerald, Morgan Stanley, and Royal Bank of Canada issued price target updates for Elevance Health, Inc. on September 12, 2026.Sep 12
• Cantor Fitzgerald began coverage and issued rating, and Morgan Stanley upgraded price objective and rating for Silence Therapeutics.Wed 20:36
• JFrog Ltd. received overweight ratings from Morgan Stanley and Cantor Fitzgerald, while its director sold shares.Jul 20